KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Labcorp Holdings (LH) EBITDA Margin (2016 - 2025)

Labcorp Holdings' EBITDA Margin history spans 17 years, with the latest figure at 7.61% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 111.0% year-over-year to 7.61%; the TTM value through Dec 2025 reached 9.92%, up 157.0%, while the annual FY2025 figure was 9.92%, 157.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 7.61% at Labcorp Holdings, down from 11.13% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 48.51% in Q4 2021 and bottomed at 4.05% in Q4 2023.
  • The 5-year median for EBITDA Margin is 10.49% (2023), against an average of 12.8%.
  • The largest annual shift saw EBITDA Margin soared 3224bps in 2021 before it plummeted -4754bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 48.51% in 2021, then tumbled by -98bps to 0.97% in 2022, then plummeted by -516bps to 4.05% in 2023, then skyrocketed by 261bps to 6.5% in 2024, then grew by 17bps to 7.61% in 2025.
  • Per Business Quant, the three most recent readings for LH's EBITDA Margin are 7.61% (Q4 2025), 11.13% (Q3 2025), and 11.18% (Q2 2025).